Selective miRNAs Modulation Fails to Activate HIV Replication in in Vitro Latency Models

Molecular Therapy - Nucleic Acids - United States
doi 10.1016/j.omtn.2019.06.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Replication Competent Virus as an Important Source of Bias in HIV Latency Models Utilizing Single Round Viral Constructs

Retrovirology
VirologyInfectious Diseases
2014English

The Viral Tat Protein Has No Essential Function in HIV-1 Replication Other Than to Activate Transcription

Retrovirology
VirologyInfectious Diseases
2009English

miRNAs and SAMHD1 Regulation in Vitro and in a Model of HIV CNS Disease

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2015English

Phytochemical Modulation of MiRNAs in Colorectal Cancer

Medicines
2019English

Why Information Systems Replication Strategy Fails in Transnational Operation

Advances in Logistics, Operations, and Management Science
2014English

High Throughput in Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Journal of Visualized Experiments
ImmunologyMolecular BiologyBiochemistryMicrobiology Chemical EngineeringNeuroscienceGenetics
2019English

In Vitro Effects of the Small-Molecule Protein Kinase C Agonists on HIV Latency Reactivation

Scientific Reports
Multidisciplinary
2016English

Heterogeneity in HIV and Cellular Transcription Profiles in Cell Line Models of Latent and Productive Infection: Implications for HIV Latency

Retrovirology
VirologyInfectious Diseases
2019English

Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces RSV Replication in Vitro

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy